China NMPA Product Recall - Orthopedic Instruments

The National Medical Products Administration (NMPA) of China published an announcement on June 1, 2023, concerning a voluntary recall initiated by medical device manufacturer Arthrex, Inc. This recall, reported by Arthrex Medical Devices (Shanghai) Co., Ltd., impacts specific orthopedic surgical instruments (National Medical Device Registration Certificate No. 20212040521). The primary reason for this action was an identified error in the selection or use of components during the manufacturing process of these devices. In response to this manufacturing discrepancy, Arthrex, Inc. has undertaken a voluntary recall of the affected products. This level of recall is typically issued when the use of the product is unlikely to cause adverse health consequences. The company's proactive measure underscores its commitment to maintaining product quality and ensuring patient safety under the regulatory oversight of the NMPA. Comprehensive information, including details on the specific models, specifications, and batch numbers of the recalled instruments, is provided in an accompanying "Medical Device Recall Event Report Form." This action is consistent with the regulatory framework governing medical device safety and quality in China.